Madras High Court Suspends Ban On Online Sale Of Medicines
Bringing relief to online pharmacists in the country, the Madras High Court on Thursday said that there will be no ban on the online sale of medicines, until a final order is delivered.
A division bench comprising Justice M Satyanarayanan and Justice P Rajamanickam has suspended the order after a group of online pharmacists approached the high court earlier this week appealing against the ban on online sale of medicines.
Until the court comes out with the final order, there will be no ban on online sale of medicines, SK Chandrakumar, a lawyer representing the Tamil Nadu Chemists and Druggists Association, a representative body of brick-and-mortar pharmacies, told BloombergQuint over the phone.
As per the previous order passed by Justice Pushpa Sathyanarayana on Monday, the ban on online sale of medicines would have come into effect at 10:30 pm on Dec. 20.
Dharmil Seth, co-founder of online pharmacy PharmEasy, while confirming the suspension of the ban added that they are now waiting for the guidelines to be released at the earliest. PharmEasy was one of the many online pharmacies that had appealed against the ban. “Thankful to the court for hearing our appeal patiently. We are, and will be committed to providing convenience to patients and bringing improvement to the entire sector using technology,” he said.
Over 1 million families use e-pharmacies a month, Seth said, adding that e-pharmacies have raised over $100 million in funding this year alone.
“This ruling validates our commitment of providing affordable and accessible medicines to customers across the country,” Pradeep Dadha, founder and chief executive officer of Netmeds, said in a statement.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
